Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:48:18 UTC |
---|
Update Date | 2021-09-26 23:01:01 UTC |
---|
HMDB ID | HMDB0249892 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide |
---|
Description | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide, also known as 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol or 1-PPMP, belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. Based on a literature review very few articles have been published on N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCCCCCCCCCCCCCC(=O)NC(CN1CCOCC1)C(O)C1=CC=CC=C1 InChI=1S/C29H50N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-28(32)30-27(25-31-21-23-34-24-22-31)29(33)26-18-15-14-16-19-26/h14-16,18-19,27,29,33H,2-13,17,20-25H2,1H3,(H,30,32) |
---|
Synonyms | Value | Source |
---|
N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]palmitamide | ChEBI | 1-PPMP | HMDB | 1-Phenyl-2-hexadecanoylamino-3-morpholino-1-propanol | HMDB | 1-Phenyl-2-palmitoylamino-3-morpholino-1-propanol | HMDB | DL-Threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol hydrochloride | HMDB | PPMP-1 | HMDB |
|
---|
Chemical Formula | C29H50N2O3 |
---|
Average Molecular Weight | 474.73 |
---|
Monoisotopic Molecular Weight | 474.382143478 |
---|
IUPAC Name | N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide |
---|
Traditional Name | N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCCCCCCCCCC(=O)NC(CN1CCOCC1)C(O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C29H50N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-28(32)30-27(25-31-21-23-34-24-22-31)29(33)26-18-15-14-16-19-26/h14-16,18-19,27,29,33H,2-13,17,20-25H2,1H3,(H,30,32) |
---|
InChI Key | OFBANDBMHLEMFA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | Aralkylamines |
---|
Alternative Parents | |
---|
Substituents | - Aralkylamine
- Monocyclic benzene moiety
- Morpholine
- Oxazinane
- Benzenoid
- 1,3-aminoalcohol
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Carboximidic acid
- Carboximidic acid derivative
- Dialkyl ether
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Organooxygen compound
- Organic oxygen compound
- Alcohol
- Organopnictogen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C)C1=CC=CC=C1)[Si](C)(C)C | 3652.3 | Semi standard non polar | 33892256 | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C)C1=CC=CC=C1)[Si](C)(C)C | 3427.9 | Standard non polar | 33892256 | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C)C1=CC=CC=C1)[Si](C)(C)C | 4182.0 | Standard polar | 33892256 | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 4138.9 | Semi standard non polar | 33892256 | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3722.3 | Standard non polar | 33892256 | N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide,2TBDMS,isomer #1 | CCCCCCCCCCCCCCCC(=O)N(C(CN1CCOCC1)C(O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 4257.3 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0aor-6955100000-c1b69a7e1545bbfecd52 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 10V, Positive-QTOF | splash10-004i-0000900000-06eee2fed144a83af04a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 20V, Positive-QTOF | splash10-0fb9-1364900000-86abe89e29608ec5b378 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 40V, Positive-QTOF | splash10-0kdl-9600200000-48fb2ec4130fb3528bf3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 10V, Negative-QTOF | splash10-00di-0000900000-d831651969a0dcc963e0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 20V, Negative-QTOF | splash10-00di-0011900000-ba2481d094cdef58176e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[1-Hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide 40V, Negative-QTOF | splash10-0ug4-4792300000-967c963a35ea47670109 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 3018 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3130 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 75125 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|